Orgagen Biosciences

Orgagen Biosciences is a private regenerative medicine and synthetic biology company developing hypoimmunogenic human induced pluripotent stem cell-derived organoids for organ replacement, tissue regeneration, and personalized drug development. The company presents itself as building universally compatible, multicellular 3D organoids with mature phenotypes from a single hiPSC source. Its business appears to center on a platform approach rather than a disclosed conventional therapeutic pipeline, with applications spanning regenerative medicine and predictive disease modeling. Publicly available information indicates the company is an early-stage venture associated with The Engine ecosystem in the Boston area.